EUVIMEDEUVIMED entdecken
Crossref

Serum trace elements during treatment in pancreatic cancer patients and their associations with cancer prognosis

Jee Ah Kim, Jong Kyun Lee, Soo-Youn Lee

Clinical Nutrition · 2024

DOI: 10.1016/j.clnu.2024.04.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nutrition, 2024. Verfasst von Jee Ah Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Trace Elements. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Science, ICT and Future Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: In this study, we assessed serum trace element concentrations in patients with pancreatic cancer and compared the results to those of healthy controls and patients with chronic pancreatitis. We evaluated the association between trace element concentrations during cancer treatment and the risk of cancer progression and mortality in pancreatic cancer patients. METHODS: A retrospective cohort study was conducted at a tertiary center in Korea. Serum trace element concentrations of cobalt (Co), copper (Cu), selenium (Se), and zinc (Zn) were measured at diagnosis using an inductively coupled plasma-mass spectrometry in 124 patients with pancreatic cancer, 50 patients with chronic pancreatitis, and 120 healthy controls. Trace elements were measured after a median of 282.5 (95% confidence interval [CI], 224.0-326.5) days from treatment initiation to assess changes in trace element concentrations during treatment. RESULTS: Serum Co concentrations were significantly higher in patients with chronic pancreatitis and pancreatic cancer compared to healthy controls, while serum Se concentrations were significantly lower. During treatment, serum concentrations of Cu, Se, and Zn significantly decreased in patients with pancreatic cancer. During the follow-up (median 152.5; 95% CI, 142.8-160.0 months), 85.5% of patients experienced progression or relapse, and 84.7% of patients died. Patients with decreased Se and Zn concentrations during treatment had a higher mortality (hazard ratio [HR], 2.10; 95% CI, 1.31-3.38; P = 0.0020 for Se; HR, 1.72; 95% CI, 1.06-2.79; P = 0.0269 for Zn) compared to those with unchanged or increased trace element concentrations during treatment. Patients with a greater reduction in Zn concentrations during treatment had a higher mortality than those with a smaller reduction (HR, 1.59; 95% CI, 1.01-2.52; P = 0.0483). Patients whose Zn status changed from normal to deficient during treatment had an increased mortality (HR, 1.76; 95% CI, 1.16-2.67, P = 0.0084). Patients with multiple (≥2) trace element deficiencies after treatment had poorer outcomes than those with no or single trace element deficiency. CONCLUSIONS: This study revealed that decreases in Se and Zn concentrations during cancer treatment were associated with adverse outcomes in terms of cancer progression and mortality in patients with pancreatic cancer. Further prospective investigations are recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsTrace ElementsHumansMaleFemaleMiddle AgedRetrospective StudiesAgedPrognosisRepublic of KoreaPancreatitis, ChronicSeleniumZincDisease ProgressionCopperCobalt

Stichwörter der Autor:innen

Cancer progressionPancreatic cancerSerum trace elementsSurvivalTreatment

Substanzen

Trace ElementsSeleniumZincCopperCobalt

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, South Korea; Department of Laboratory Medicine, Kangbuk Samsung H…
  • Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, South Korea. Electronic address: jongk.lee@samsung.com.
  • Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, South Korea. Electronic address: suddenbz@skku.edu.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science, ICT and Future Planning

Zitieren

APA

Kim, J. A., Lee, J. K., & Lee, S. Y. (2024). Serum trace elements during treatment in pancreatic cancer patients and their associations with cancer prognosis. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2024.04.012

Vancouver

Kim JA, Lee JK, Lee SY. Serum trace elements during treatment in pancreatic cancer patients and their associations with cancer prognosis. Clinical Nutrition. 2024. doi:10.1016/j.clnu.2024.04.012

BibTeX
@article{Kim2024,
  author = {Kim, Jee Ah and Lee, Jong Kyun and Lee, Soo-Youn},
  title = {Serum trace elements during treatment in pancreatic cancer patients and their associations with cancer prognosis},
  journal = {Clinical Nutrition},
  year = {2024},
  doi = {10.1016/j.clnu.2024.04.012}
}
Kostenlos starten →